RBC Capital analyst Michael Carroll maintained a Buy rating on CareTrust REIT (NASDAQ:CTRE) on Monday, setting a price target of $26, which is approximately 13.29% above the present share price of $22.95.
Carroll expects CareTrust REIT to post earnings per share (EPS) of $0.21 for the second quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Strong Buy rating of shares in CareTrust REIT, with an average price target of $26.
The analysts price targets range from a high of $26 to a low of $26.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $45.25 million and a net profit of $25.94 million. The company's market cap is $2.22 billion.
According to TipRanks.com, RBC Capital analyst Michael Carroll is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 10.9% and a 74.33% success rate.
CareTrust REIT, Inc. operates as real estate investment company, which engages in the ownership, acquisition, and leasing of healthcare-related properties. It offers independent living, memory care, and assisted, and skilled nursing facilities. The company was founded on October 29, 2013 and is headquartered in San Clemente, CA.